| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.89B | 7.56B | 6.81B | 6.60B | 6.69B | 5.35B |
| Gross Profit | 4.52B | 4.23B | 3.54B | 3.21B | 3.56B | 2.82B |
| EBITDA | 2.79B | 2.42B | 1.76B | 1.80B | 2.34B | 1.86B |
| Net Income | 2.18B | 1.93B | 1.35B | 1.30B | 1.59B | 1.19B |
Balance Sheet | ||||||
| Total Assets | 11.48B | 11.41B | 9.76B | 8.63B | 13.55B | 11.92B |
| Cash, Cash Equivalents and Short-Term Investments | 7.98B | 7.18B | 5.84B | 5.21B | 10.27B | 8.42B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.99B | 2.51B | 2.20B | 1.95B | 2.21B | 1.87B |
| Stockholders Equity | 8.50B | 8.89B | 7.56B | 6.68B | 11.34B | 10.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.47B | 1.41B | 1.07B | 2.31B | 904.54M |
| Operating Cash Flow | 0.00 | 1.47B | 1.43B | 1.12B | 2.34B | 908.62M |
| Investing Cash Flow | 0.00 | -316.98M | -236.62M | -198.56M | -94.61M | -150.25M |
| Financing Cash Flow | 0.00 | -531.29M | -571.58M | -5.98B | -396.85M | -582.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥9.03B | 20.68 | ― | 0.99% | -0.69% | -6.98% | |
76 Outperform | ¥37.95B | 18.67 | ― | 1.92% | 20.81% | 68.06% | |
75 Outperform | ¥14.76B | 9.32 | ― | 3.14% | 3.58% | 0.23% | |
75 Outperform | ¥19.02B | 30.80 | ― | 3.14% | 0.50% | -2.92% | |
64 Neutral | ¥35.25B | 20.10 | ― | ― | 27.97% | -5.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | ¥24.91B | 39.28 | ― | ― | 20.84% | 10.41% |